Mainz Biomed Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun '24 Jun 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Revenue	0.92	0.9	0.53	0.58	0.49	0.28
Revenue Growth (YoY)	16.23%	69.00%	-8.22%	16.98%	75.40%	-
Cost of Revenue	0.38	0.39	0.35	0.4	0.37	0.34
Gross Profit	0.54	0.51	0.18	0.18	0.12	-0.06
Selling, General & Admin	15.23	17.56	21.61	9.42	0.48	0.61
Research & Development	7.35	9.59	5.02	0.48	0.31	0.25
Operating Expenses	22.58	27.15	26.63	9.9	0.8	0.86
Operating Income	-22.04	-26.64	-26.44	-9.72	-0.67	-0.92
Interest Expense	-1.13	-0.56	-0.29	-0.34	-0.27	-0.2
Other Non Operating Income (Expenses)	0.53	0.2	0.35	0.39	0.33	0.17
EBT Excluding Unusual Items	-22.64	-27.01	-26.39	-9.67	-0.62	-0.96
Merger & Restructuring Charges	-	-	-	-2.02	0.03	-
Other Unusual Items	0.14	0.71	-	-	-	-
Pretax Income	-22.51	-26.3	-26.39	-11.69	-0.59	-0.96
Net Income	-22.51	-26.3	-26.39	-11.69	-0.59	-0.96
Net Income to Common	-22.51	-26.3	-26.39	-11.69	-0.59	-0.96
Shares Outstanding (Basic)	1	0	0	0	0	0
Shares Outstanding (Diluted)	1	0	0	0	0	0
Shares Change (YoY)	-96.58%	14.73%	96.34%	28.60%	-	-
EPS (Basic)	-44.98	-64.76	-74.55	-64.85	-4.19	-6.83
EPS (Diluted)	-44.98	-64.76	-74.55	-64.85	-4.19	-6.83
Free Cash Flow	-19.6	-23.14	-15.43	-3.24	-0.48	-0.42
Free Cash Flow Per Share	-39.17	-56.98	-43.59	-17.96	-3.41	-2.97
Gross Margin	58.98%	56.92%	34.38%	30.76%	24.94%	-21.77%
Operating Margin	-2402.78%	-2975.47%	-4990.60%	-1684.36%	-136.50%	-327.62%
Profit Margin	-2453.86%	-2936.50%	-4979.90%	-2024.79%	-118.91%	-340.11%
Free Cash Flow Margin	-2136.98%	-2583.83%	-2911.63%	-560.67%	-96.93%	-148.01%
EBITDA	-21.59	-26.07	-26.28	-9.65	-0.61	-0.87
EBITDA Margin	-	-	-	-	-124.25%	-
D&A For EBITDA	0.45	0.57	0.16	0.07	0.06	0.05
EBIT	-22.04	-26.64	-26.44	-9.72	-0.67	-0.92
EBIT Margin	-	-	-	-	-136.50%	-
Advertising Expenses	-	-	-	-	-	0.02

Updated Oct 18, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q